News

EMPHNET Supports Veterinarians Training on Fluorescent Polarization Assay (FPA) for Brucellosis in Jordan
    EMPHNET Supports Veterinarians Training on Fluorescent Polarization Assay (FPA) for Brucellosis in Jordan
    May 22, 2019   |  Jordan

    Brucellosis is an infectious disease caused by bacteria. People can get the disease when they are in contact with infected animals or animal products contaminated with the bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others.

    Accordingly, EMPHNET in collaboration with the Centers for Disease Control and Prevention (CDC) and Ellie LLC conducted a three-day refresher course on Fluorescent Polarization Assay (FPA), a rapid diagnostic test for Brucellosis.

    As part of the pioneering project titled “Evaluating the Impact of Enhanced Laboratory Based Surveillance of Animal and Human Brucellosis in Jordan,” EMPHNET implemented three simultaneous three-day trainings in East Amman, Mafraq, and Karak between April 29 and May 1, 2019. The Veterinary Directorates of each respective location participated in the capacity-building exercise. The veterinarians were vigorously trained on the new technologies and techniques for detecting Brucella antibodies in serum and milk from infected animals in the field and laboratory. The practical and life-saving test is an amazing diagnostic tool that will bolster field capacities for identifying animals affected by Brucellosis.

    To complement these training efforts, the diagnostics test was introduced to the Ministry of Agriculture; as well, portable FPA Sentry 200 kits equipped with laptops were delivered to the training locations to enhance the participant learning experience.

    The successful three-day FPA training is but one example of EMPHNET’s constant effort to build the capacities of local health practitioners in the EMR. We believe it is our duty as health professionals to strengthen public health frameworks in the region; for a healthier, better trained, and improved well-being of people living in the EMR.

    For more information on Brucellosis please visit   https://www.cdc.gov/brucellosis/.